Efficacy and Safety of Glecaprevir/Pibrentasvir in Participants with Chronic HCV Infection and Comorbidities or Multiple Concomitant Medications: An Integrated Analysis

Abstract Introduction Glecaprevir/pibrentasvir (G/P) is globally approved for the treatment of chronic hepatitis C virus (HCV) infection and for acute HCV infection in the USA. The efficacy and safety of G/P has been clinically demonstrated in participants with chronic HCV. We used clinical trial da...

תיאור מלא

מידע ביבליוגרפי

Principais autores:	Curtis Cooper, Shweta A. Raina, Lisa Johnson, Jordan J. Feld, Ashley Brown, Anthony Martinez, Brian Conway, Stuart C. Gordon, Tarik Asselah, Liz Uribe, Moming Li, Alexandru Iacob, John Marcinak, Dimitri Semizarov, Stanislas Pol
פורמט:	Artigo
שפה:	Inglês
יצא לאור:	Adis, Springer Healthcare 2026-04-01
סדרה:	Infectious Diseases and Therapy
נושאים:	Chronic HCV infection Glecaprevir Pibrentasvir Comorbidity Concomitant medication Polypharmacy
גישה מקוונת:	https://doi.org/10.1007/s40121-026-01339-y
תגים:	הוספת תג אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!